Document Detail


Contribution of endothelium-derived nitric oxide to coronary arterial distensibility: an in vivo two-dimensional intravascular ultrasound study.
MedLine Citation:
PMID:  7900624     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Reduced epicardial coronary arterial distensibility associated with early atherosclerosis may be mediated in part by reduced nitric oxide (NO) release. To directly assess the contribution of endogenous NO to coronary arterial distensibility, we examined the effect of intracoronary N omega nitro-L-arginine methyl ester (L-NAME), an inhibitor of NO synthase, and L-arginine, its natural substrate, on the circumflex artery in seven anesthetized dogs. We also used intracoronary acetylcholine to examine the effect of pharmacologically induced NO release on coronary distensibility. Electrocardiographically gated measurements of epicardial coronary lumen area were made by a blinded observer from images obtained with a 4.3F, 30 MHz intravascular ultrasound catheter. Aortic root pressure was continuously monitored, and neither systemic arterial pressure nor pulse pressure changed significantly with intracoronary drug administration. Change in lumen area (delta LA) from end systole to end diastole was measured, and an arterial distensibility index was calculated. Delta LA increased with acetylcholine from 8.2% +/- 0.5% at baseline to 16.3% +/- 2.8% (10(-6) mol/L; p < 0.001), with increases in both end-systolic and end-diastolic lumen area and decreased delta LA to 3.1% +/- 1.3% (p < 0.01). Lumen area and delta LA were both restored to baseline by L-arginine (10(-4)). The calculated distensibility index of the epicardial coronary artery was enhanced by acetylcholine, reduced below baseline by L-NAME, and restored to baseline by L-arginine.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
K Sudhir; W L Mullen; D Hausmann; P J Fitzgerald; T M Chou; P G Yock; K Chatterjee
Related Documents :
9594014 - Haemodynamic effects of the intravenous administration of growth hormone in anaesthetiz...
181164 - Myocardial tissue recruitment in the dog as determined by double tracer dilution method.
2245024 - Coronary myogenic responses to abrupt changes in aortic blood pressure in anaesthetized...
7361904 - Aerobic limit of the heart perfused at constant pressure.
16553284 - Influence of aminoguanidine, an inhibitor of inducible nitric oxide synthase, on the pu...
9308604 - The kidney in blood pressure regulation and development of hypertension.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American heart journal     Volume:  129     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1995 Apr 
Date Detail:
Created Date:  1995-04-27     Completed Date:  1995-04-27     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  726-32     Citation Subset:  AIM; IM    
Affiliation:
Cardiovascular Research Institute, University of California, San Francisco.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acetylcholine / pharmacology
Angioplasty, Transluminal, Percutaneous Coronary / adverse effects
Animals
Arginine / analogs & derivatives,  pharmacology
Coronary Vessels / drug effects,  physiology*,  ultrasonography*
Dogs
Endothelium, Vascular / drug effects,  injuries
NG-Nitroarginine Methyl Ester
Nitric Oxide / antagonists & inhibitors,  physiology*
Nitroglycerin / pharmacology
Ultrasonography, Interventional / methods*
Vascular Resistance / drug effects,  physiology
Chemical
Reg. No./Substance:
10102-43-9/Nitric Oxide; 50903-99-6/NG-Nitroarginine Methyl Ester; 51-84-3/Acetylcholine; 55-63-0/Nitroglycerin; 74-79-3/Arginine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Doppler evaluations of left ventricular diastolic filling and pulmonary wedge pressure provide simil...
Next Document:  Pattern of coronary artery disease in patients with ventricular tachycardia and fibrillation exposed...